Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Federal University of ABC
With
University of Sao Paulo
Coordination for the Improvement of Higher Education Personnel
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy individuals, both sexes, aged between 18 and 40 years (first arm).
Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia (chronic widespread pain), primary chronic headache and orofacial pain, chronic primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;
In the case of post-COVID-19 pain, the symptoms must be present for at least 12 weeks. The complaints of pain, fatigue, and/or changes in mental health should have started after infection by SARS-Cov-2.
You may not be if
Individuals who present dysautonomia;
obese individuals with a high abdominal fat index characterized by a waist/hip ratio of 0.80 for women and 0.95 for men;
heart disease;
diabetes mellitus;
vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation test, arc test, side-lying maneuver, and post-head-shake nystagmus;
diagnosis of epilepsy or first-degree family history of epilepsy
fever;
chronic consumption of alcohol, or other recreational drugs;
presence of contraindications for the use of non-invasive neuromodulation;
those who become ill with COVID-19 during the data collection period;
those who are unable to answer the evaluation questionnaires;
those with clinical instability;
those who have a previous history of chronic pain or fatigue before contracting COVID-19;
those who have neuropathic pain.
Clareo Health | Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
